티스토리 뷰
ELISA,항체,단백질
[Inhibitors/„DON“ compounds] Z-DON-Val-Pro-Leu-OMe; Z-DON [Z006][CAS no. -]_ZEDIRA - 코아사이언스
코피디 2024. 6. 3. 11:31안녕하세요!
ZEDIRA GmbH 수입/공급 업체 코아사이언스 입니다.
자세한 상품 정보 및 관련 문의는 전화 02-858-0328 또는 info@coresciences.co.kr로 문의주시기 바랍니다.
감사합니다!
Z-DON-Val-Pro-Leu-OMe
=Z-DON; Benzyloxycarbonyl-(6-Diazo-5-oxonorleucinyl)-L-Valinyl-L-Prolinyl-L-Leucinmethylester
Cat.# Z006 / Size: 10mg
Synonym
Benzyloxycarbonyl-(6-Diazo-5-oxonorleucinyl)-L-Valinyl-L-Prolinyl-L-Leucinmethylester
Molecular Formula
C31H44N6O8
Molecular Weight
628.72
Purity by HPLC
>95 % (214 nm)
Appearance
pale yellow solid
Solubility
100 μM in 2% (v/v) DMSO or 2% (v/v) Ethanol / aqueous buffers.
Pre-dissolve the complete 10 mg (adjust to the weight given on the vial) in 318 μl DMSO or EtOH (50 mM).
DMSO stock solutions are sterile and can be stored at -20°C for at least 6 months. To avoid too many freeze-thaw cycles, we strongly recommend storage of aliquots.
Take e.g. 10 μl of the 50 mM stock solution and add 90 μl DMSO (or EtOH) to obtain a 5 mM stock solution - dilute by adding 4.9 ml buffer or assay components to obtain your final assay solution (100 μM).
In case your assay or experimental setting does not tolerate these DMSO levels, we recommend the following procedure:
Pre-dissolve the complete 10 mg (adjust to the weight given on the vial) in 159 μl DMSO (100 mM). Make sure that the compound is dissolved properly.
Take e.g. 10 μl of the 100 mM stock solution and add 9.99 ml buffer/ assay components (1:1,000) to obtain your final assay solution (100 μM).
In our experience, the compound dissolves in Tris-buffered saline even if locally a milky precipitate may form initially.
Pre-dissolve the complete 10 mg (adjust to the weight given on the vial) in 318 μl DMSO or EtOH (50 mM).
DMSO stock solutions are sterile and can be stored at -20°C for at least 6 months. To avoid too many freeze-thaw cycles, we strongly recommend storage of aliquots.
Take e.g. 10 μl of the 50 mM stock solution and add 90 μl DMSO (or EtOH) to obtain a 5 mM stock solution - dilute by adding 4.9 ml buffer or assay components to obtain your final assay solution (100 μM).
In case your assay or experimental setting does not tolerate these DMSO levels, we recommend the following procedure:
Pre-dissolve the complete 10 mg (adjust to the weight given on the vial) in 159 μl DMSO (100 mM). Make sure that the compound is dissolved properly.
Take e.g. 10 μl of the 100 mM stock solution and add 9.99 ml buffer/ assay components (1:1,000) to obtain your final assay solution (100 μM).
In our experience, the compound dissolves in Tris-buffered saline even if locally a milky precipitate may form initially.
Application
Irreversible inhibitor of tissue transglutaminase
IC50 ~ 0.02 μM; Cell permeable at 40 μM
Z-DON-Val-Pro-Leu-OMe is able to trap tissue transglutaminase in the open conformation. The structure is deposit at PDB (3S3J).
IC50 ~ 0.02 μM; Cell permeable at 40 μM
Z-DON-Val-Pro-Leu-OMe is able to trap tissue transglutaminase in the open conformation. The structure is deposit at PDB (3S3J).
Storage
Store at -20°C, desiccate
Z-DON is stable (>70%) in phosphate-buffered saline (PBS, pH 7.4, 37°C) for at least 3 days.
Z-DON is stable (>70%) in phosphate-buffered saline (PBS, pH 7.4, 37°C) for at least 3 days.
Reference(s)
Schaertl, S. et al. J. Biomol. Screen. 2010, 15, 478.
Verhaar, R. et al. Neurochem. Int. 2011, 58, 785.
McConoughey, S.J. et al. EMBO Mol. Med. 2010, 2, 349.
Lauzier, A. et al. Arthritis Res. Ther. 2012, 14, R159.
Verhaar, R. et al. Neurochem Int. 2013, 62, 486.
Fischer J. et al. J. Invest. Dermatol. 2013, 133, 1170.
Lauzier, A. et al. Arthritis Research & Therapy 2012, 14, R159.
Wang Z. et al. Cell Death & Dis. 2013, 4, e808.
de Jager, M. et al. J. Neurochem. 2015, 134, 1116.
de Jager, M. et al. Neuropathol. Appl. Neurobiol. 2016, 42, 255.
Wilhelmus, M. et al. Sci Rep. 2016, 6, 20569.
van der Wildt, B. et al. Nucl. Med. Biol. 2016, 43, 232.
Recktenwald, C. et al. J. Biol. Chem. 2016, 291, 13580.
Singh, G. et al. J. Biol. Chem. 2016, 291, 9119.
Espitia Pinzon, N. et al. Sci Rep. 2017, 7, 40995.
Katt, P.W. et al. Mol. Pharmaceutics 2015, 12, 46-55.
Algarni A.S. et al. Biochem. Pharmacol. 2017, 128, 55-73.
Chrobok, N.L. et al. PLoS ONE 2018, 13, e0209522.
Verhaar, R. et al. Neurochem. Int. 2011, 58, 785.
McConoughey, S.J. et al. EMBO Mol. Med. 2010, 2, 349.
Lauzier, A. et al. Arthritis Res. Ther. 2012, 14, R159.
Verhaar, R. et al. Neurochem Int. 2013, 62, 486.
Fischer J. et al. J. Invest. Dermatol. 2013, 133, 1170.
Lauzier, A. et al. Arthritis Research & Therapy 2012, 14, R159.
Wang Z. et al. Cell Death & Dis. 2013, 4, e808.
de Jager, M. et al. J. Neurochem. 2015, 134, 1116.
de Jager, M. et al. Neuropathol. Appl. Neurobiol. 2016, 42, 255.
Wilhelmus, M. et al. Sci Rep. 2016, 6, 20569.
van der Wildt, B. et al. Nucl. Med. Biol. 2016, 43, 232.
Recktenwald, C. et al. J. Biol. Chem. 2016, 291, 13580.
Singh, G. et al. J. Biol. Chem. 2016, 291, 9119.
Espitia Pinzon, N. et al. Sci Rep. 2017, 7, 40995.
Katt, P.W. et al. Mol. Pharmaceutics 2015, 12, 46-55.
Algarni A.S. et al. Biochem. Pharmacol. 2017, 128, 55-73.
Chrobok, N.L. et al. PLoS ONE 2018, 13, e0209522.
Note
INTENDED FOR RESEARCH USE ONLY, NOT FOR USE IN HUMAN, THERAPEUTIC OR DIAGNOSTIC APPLICATIONS.
Related Products
* 본 상품은 오직 연구용으로만 사용 가능합니다. 인체 및 제품화에 사용하실 수 없습니다.
코아사이언스 coresciences ZEDIRA GmbH, Darmstadt, Germany Korea 한국 대리점 distributor 트랜스글루타미나제 트랜스글루타미나아제 트랜스글루타미네이스 트랜스글루타미네이즈 활성 분석 측정 키트
'ELISA,항체,단백질' 카테고리의 다른 글
공지사항
최근에 올라온 글
최근에 달린 댓글
- Total
- Today
- Yesterday
링크
TAG
- OLED
- OPV
- 코아사이언스
- 면역화학분석
- 조직절편제작
- Sterlitech
- matrix-driven delivery pellet
- allview PAGE buffer
- gradient gel
- Funakoshi
- material science
- time release pellets
- solar cells
- 미니멸균백
- 바이오하자드백
- 파라핀 블록
- Coresciences
- 오토클레이브백
- 조직절편
- 고수용성 콘드로이틴
- 후나코시
- 건스터바이오텍
- filter
- 조직염색절편제작
- 연속절편
- 콘드로이틴 황산 올리고당
- 형광염색
- 파라핀 블럭
- 막필터
- 바이오헤저드백
일 | 월 | 화 | 수 | 목 | 금 | 토 |
---|---|---|---|---|---|---|
1 | 2 | |||||
3 | 4 | 5 | 6 | 7 | 8 | 9 |
10 | 11 | 12 | 13 | 14 | 15 | 16 |
17 | 18 | 19 | 20 | 21 | 22 | 23 |
24 | 25 | 26 | 27 | 28 | 29 | 30 |
글 보관함